2.3 The list price is £4,533 per 300 mg/3 ml concentrate for solution for infusion vial; £16,621 per 1,100 mg/11 ml concentrate for solution for infusion vial (excluding VAT; company submission).
2.4 The company has a commercial arrangement. This makes ravulizumab available to the NHS with a discount. The size of the discount is commercial in confidence. It is the company's responsibility to let relevant NHS organisations know details of the discount.